Compras y ventas de directivos de Stryker (SYK)
Qué compran y venden los consejeros y directivos del S&P 500 en sus propias empresas, tal cual lo presentan en los Formularios 4 de la SEC (2 días hábiles de plazo): cada fila con su código oficial y sin filtrar nada.
Las compras en mercado abierto (código P) son la señal rara, en verde; las ventas (código S) son frecuentes y muchas van programadas (10b5-1). La tabla II (derivados) no se incluye: sus precios son de ejercicio, no de mercado. Guía: compras de directivos.
| Fecha | Ticker | Directivo | Cargo | Acciones | Precio | Importe | % posición | Tipo / documento |
|---|
Descargar estas transacciones en CSV Sin cuenta y sin registro. Los datos son públicos: salen de los Formularios 4 de la SEC.
Compras y ventas de directivos de Stryker Corporation (SYK): 5 compras y 15 ventas
84 transacciones de la tabla I del Formulario 4 declaradas ante la SEC por directivos de Stryker Corporation entre el 2025-08-27 y el 2026-09-28 (histórico de 15 meses): 5 compras y 15 ventas en mercado abierto, y 64 transacciones con otros códigos del Formulario 4, desglosados uno a uno más abajo. La mayor operación en mercado abierto es una venta de $100,8M de Stryker Ronda E el 2026-08-18.
Compras y ventas de directivos de Stryker en los últimos 12 meses
Entre el 21 oct 2025 y el 20 oct 2026, los directivos de Stryker declararon 14 ventas por $586,1M en mercado abierto, y ninguna compra.
Quien más vendió fue Stryker Ronda E (Consejero): $580,9M en 7 ventas, de 8 vendedores distintos.
La mayor operación del período fue una venta de $100,8M el 18 ago 2026, de Stryker Ronda E (Consejero). Formulario 4 en sec.gov (0001242914-26-000010).
De las 14 ventas, 1 (el 7%, $1,4M) lleva en el Formulario 4 la marca de plan 10b5-1, es decir, se programó con meses de antelación; las otras 13 no la llevan.
En los tres últimos meses hay 4 ventas, frente a 3 en los tres anteriores. La última venta es del 21 ago 2026.
Frente a su sector (Salud, 59 empresas con página de directivos en esta web), en las mismas fechas la mediana es de 9 ventas y 0 compras en mercado abierto. Stryker tiene más ventas que 40 de las otras 58, es la 2.ª de 59 por dinero neto vendido, y 19 de las 59 tienen al menos una compra.
Las 20 operaciones más importantes
Primero las 5 compras en mercado abierto y después el resto, cada tipo de mayor a menor importe. El histórico completo está en la herramienta de arriba, ya buscado.
Ver las 84 operaciones de SYK en el histórico completo →
| Operación | Declarada | Directivo | Cargo | Importe | Código | Documento |
|---|---|---|---|---|---|---|
| 2019-06-26 | 2026-09-02 | Brainerd Mary K | Consejero | $13k | P — Compra en mercado abierto Tenencia indirecta, a través de: Held by Husband's Revocable Trust | SEC |
| 2020-05-12 | 2026-09-02 | Brainerd Mary K | Consejero | $7k | P — Compra en mercado abierto Tenencia indirecta, a través de: Held by Husband's Revocable Trust | SEC |
| 2022-11-22 | 2026-09-02 | Brainerd Mary K | Consejero | $4k | P — Compra en mercado abierto Tenencia indirecta, a través de: Held by Husband's Revocable Trust Nota del Formulario 4 (texto original de la SEC, en inglés)F2 Includes 11 shares previously held by the Reporting Person's IRA, which were transferred to her husband's Revocable Trust on September 1, 2026. | SEC |
| 2019-09-12 | 2026-09-02 | Brainerd Mary K | Consejero | $2k | P — Compra en mercado abierto Tenencia indirecta, a través de: Held by IRA Nota del Formulario 4 (texto original de la SEC, en inglés)F1 The shares purchased in the Reporting Person's IRA were subsequently transferred to her husband's Revocable Trust on September 1, 2026. | SEC |
| 2020-06-12 | 2026-09-02 | Brainerd Mary K | Consejero | $557 | P — Compra en mercado abierto Tenencia indirecta, a través de: Held by Husband's Revocable Trust | SEC |
| 2026-08-18 | 2026-08-20 | Stryker Ronda E | Consejero | $100,8M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 9 notas del Formulario 4 (texto original de la SEC, en inglés)F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $331.15 to $332.11, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F2 Includes 560 shares previously held directly which were transferred to the Revocable Trust on August 18, 2026. F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $332.17 to $333.085, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $333.16 to $334.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $334.21 to $335.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $335.15 to $336.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F7 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.15 to $337.145, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F8 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $337.15 to $338.13, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F9 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $338.15 to $339.10, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2025-11-06 | 2025-11-07 | Stryker Ronda E | Consejero | $97,6M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 7 notas del Formulario 4 (texto original de la SEC, en inglés)F8 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $349.455 to $350.195, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F9 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $350.71 to $351.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F10 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $351.73 to $352.695, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F11 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $352.70 to $353.695, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F12 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $353.70 to $354.695, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F13 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $354.71 to $355.68, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F14 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $355.76 to $355.84, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2026-05-26 | 2026-05-28 | Stryker Ronda E | Consejero | $96,8M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 7 notas del Formulario 4 (texto original de la SEC, en inglés)F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $310.35 to $310.995, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $311.00 to $311.998, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $312.00 to $312.995, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $313.00 to $313.985, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $314.00 to $314.985, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $315.00 to $315.69, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F7 Includes 679,642 shares previously held by the L. Lee Stryker Trust which were transferred to the Revocable Trust on May 28, 2026. | SEC |
| 2026-02-05 | 2026-02-06 | Stryker Ronda E | Consejero | $91,0M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 7 notas del Formulario 4 (texto original de la SEC, en inglés)F13 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.79 to $361.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F14 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.79 to $362.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F15 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.79 to $363.785, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F16 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $363.79 to $364.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F17 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.79 to $365.785, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F18 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $365.79 to $366.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F19 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.79 to $367.32, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2026-02-04 | 2026-02-06 | Stryker Ronda E | Consejero | $90,7M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 12 notas del Formulario 4 (texto original de la SEC, en inglés)F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $358.005 to $358.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F2 Includes 5,223 shares previously held directly which were transferred to the Revocable Trust on February 2, 2026. F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $359.01 to $360.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.01 to $361.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.01 to $362.01, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.09 to $363.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F7 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $363.09 to $364.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F8 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $364.09 to $365.08, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F9 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $365.14 to $366.09, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F10 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $366.115 to $366.99, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F11 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $367.37 to $368.315, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F12 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.47 to $368.635, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2025-11-05 | 2025-11-07 | Stryker Ronda E | Consejero | $87,0M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 7 notas del Formulario 4 (texto original de la SEC, en inglés)F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $353.485 to $354.475, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $354.48 to $355.47, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $355.48 to $356.475, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $356.48 to $357.47, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $357.48 to $358.475, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F6 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $358.48 to $359.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F7 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $359.79 to $359.80, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2026-08-19 | 2026-08-20 | Stryker Ronda E | Consejero | $17,0M | S — Venta en mercado abierto Tenencia indirecta, a través de: By Revocable Trust 12 notas del Formulario 4 (texto original de la SEC, en inglés)F10 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $331.74 to $332.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F11 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $332.81 to $333.775, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F12 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $333.81 to $334.20, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F13 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $335.05 to $335.06, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F14 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.20 to $337.14, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F15 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $337.31 to $338.255, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F16 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $338.30 to $339.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F17 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $339.30 to $340.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F18 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $340.30 to $341.27, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F19 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $341.30 to $342.295, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F20 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $342.32 to $343.29, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F21 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $343.31 to $343.90, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2026-05-11 | 2026-05-12 | Fink M Kathryn | VP, Chief HR Officer | $2,5M | S — Venta en mercado abierto Tenencia indirecta, a través de: By 2023 Mary Fink Living Trust Nota del Formulario 4 (texto original de la SEC, en inglés)F2 These shares, which were previously owned directly, were transferred to the Living Trust on March 26, 2026. | SEC |
| 2026-05-28 | 2026-05-29 | Fletcher Robert S | VP, Chief Legal Officer | $1,4M | S — Venta en mercado abierto (programada 10b5-1)5 notas del Formulario 4 (texto original de la SEC, en inglés)F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 26, 2026. F2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $305.59 to $305.665, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $306.05 to $306.945, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $307.06 to $307.76, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. F5 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $308.78 to $308.79, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2025-11-14 | 2025-11-17 | Berry William E Jr | VP, Chief Accounting Officer | $714k | S — Venta en mercado abierto | SEC |
| 2026-08-18 | 2026-08-18 | King Debra | See Remarks | $278k | S — Venta en mercado abiertoNota del Formulario 4 (texto original de la SEC, en inglés)F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $336.255 to $336.304, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2025-08-25 | 2025-08-27 | Menon Viju | Group President | $195k | S — Venta en mercado abierto | SEC |
| 2026-02-02 | 2026-02-03 | Pierce James Andrew | Group President | $175k | S — Venta en mercado abiertoNota del Formulario 4 (texto original de la SEC, en inglés)F1 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $368.7534 to $368.92, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. | SEC |
| 2026-08-21 | 2026-08-26 | Crotty Dylan Bram | Group President | $145k | S — Venta en mercado abierto Tenencia indirecta, a través de: By Dylan B Crotty Trust | SEC |
| 2025-11-20 | 2025-11-20 | Wells Preston Wendell | VP, Chief Financial Officer | $60k | S — Venta en mercado abierto | SEC |
El saldo del período: cuánto dinero entra y cuánto sale
En los Formularios 4 presentados entre el 27 ago 2025 y el 28 sept 2026, el mercado abierto de Stryker Corporation suma 5 compras por $27k y 15 ventas por $586,3M. El saldo es de $586,3M a favor de las ventas.
Solo cuentan los códigos P y S, donde el directivo pone o saca su propio dinero. Que el saldo de Stryker Corporation salga vendedor es lo habitual en el S&P 500, donde buena parte del sueldo se cobra en acciones. No es una recomendación de comprar ni de vender: es lo que se declaró.
Todas las transacciones, código por código
| Código | Qué significa | Operaciones | Importe declarado |
|---|---|---|---|
| F | Retención fiscal (acciones entregadas por impuestos) | 22 | $78,2M |
| A | Adjudicación o premio de acciones | 19 | $0 |
| S | Venta en mercado abierto | 15 | $586,3M |
| M | Ejercicio de opciones | 13 | $27,9M |
| G | Regalo o donación | 6 | $0 |
| P | Compra en mercado abierto | 5 | $27k |
| J | Otra operación (explicada en el propio filing) | 4 | $0 |
| Total | Todo lo declarado en el período | 84 | $692,5M |
35 de las 84 filas no traen un importe utilizable en el Formulario 4: cuentan como operación y suman $0. Las etiquetas son las del índice de códigos de la SEC.
Quién ha operado
En los 15 meses del histórico han declarado operaciones de Stryker Corporation 20 personas o entidades distintas. De ellas, 1 compró en mercado abierto y 9 vendieron. Se cuentan por su CIK, el número fijo que la SEC da a cada declarante, y no por el nombre, que cada uno escribe a su manera.
De los 9 que vendieron en mercado abierto (15 ventas en total), los tres que más vendieron suman $584,8M de los $586,3M: el 100% del dinero en tres personas.
| Declarante | Cargo | Transacciones | Comprado (nº) | Vendido (nº) | Última declarada |
|---|---|---|---|---|---|
| Stryker Ronda E | Consejero | 13 | — | $580,9M (7) | 2026-08-20 |
| Fink M Kathryn | VP, Chief HR Officer | 8 | — | $2,5M (1) | 2026-08-04 |
| Fletcher Robert S | VP, Chief Legal Officer | 5 | — | $1,4M (1) | 2026-08-04 |
| Berry William E Jr | VP, Chief Accounting Officer | 6 | — | $714k (1) | 2026-03-24 |
| King Debra | See Remarks | 3 | — | $278k (1) | 2026-08-18 |
| Menon Viju | Group President | 4 | — | $195k (1) | 2026-03-24 |
| Pierce James Andrew | Group President | 9 | — | $175k (1) | 2026-03-24 |
| Crotty Dylan Bram | Group President | 2 | — | $145k (1) | 2026-08-26 |
Se enseñan los 8 que más dinero movieron, de 20. Los demás están en el histórico completo, que se abre con el enlace de arriba. El nombre lleva a todas sus operaciones, en cualquier empresa. «Transacciones» cuenta cualquier código; el dinero, solo mercado abierto. Cargo: el de su última declaración.
Mes a mes
Por el mes en que se operó, no en el que se presentó el formulario; los meses sin operaciones van a cero. El mes con más movimiento fue nov 2025: 0 compras y 4 ventas, por $185,4M. 10 de los 15 meses no tienen ninguna. 5 operaciones se hicieron antes del inicio de la ventana y se declararon con retraso: están en el histórico y en las tablas de arriba, pero caen fuera de este calendario.
| Mes | Compras | Importe | Ventas | Importe |
|---|---|---|---|---|
| ago 2025 | 0 | $0 | 1 | $195k |
| sept 2025 | 0 | $0 | 0 | $0 |
| oct 2025 | 0 | $0 | 0 | $0 |
| nov 2025 | 0 | $0 | 4 | $185,4M |
| dic 2025 | 0 | $0 | 0 | $0 |
| ene 2026 | 0 | $0 | 0 | $0 |
| feb 2026 | 0 | $0 | 3 | $181,9M |
| mar 2026 | 0 | $0 | 0 | $0 |
| abr 2026 | 0 | $0 | 0 | $0 |
| may 2026 | 0 | $0 | 3 | $100,7M |
| jun 2026 | 0 | $0 | 0 | $0 |
| jul 2026 | 0 | $0 | 0 | $0 |
| ago 2026 | 0 | $0 | 4 | $118,2M |
| sept 2026 | 0 | $0 | 0 | $0 |
| oct 2026 | 0 | $0 | 0 | $0 |
El último mes puede ir incompleto: el Formulario 4 se presenta hasta dos días hábiles después. La tabla no dice si el patrón es bueno o malo; dice cuándo pasó.
Ficha de análisis de Stryker Corporation (SYK) →
Otras empresas de Salud con operaciones de directivos
Están las 500 en el índice de la sección →
Qué directivos están comprando acciones de su propia empresa →
Cómo leer estos datos
1 de las 15 ventas de la tabla van marcadas como programadas (plan 10b5-1): se firman con meses de antelación y se ejecutan solas, así que no dicen lo que el directivo piensa hoy. Las 5 compras en mercado abierto (código P) de Stryker son la señal rara: los directivos ya cobran en acciones, y comprar más es poner dinero propio. La última presentación es del 28 sept 2026, y el Formulario 4 llega hasta dos días hábiles después de operar.
13 de las 20 filas de la tabla llevan notas al pie del propio Formulario 4, plegadas en la columna del código y copiadas tal cual, en inglés; una fila sin nota es que el formulario no la trae.
Guía: Compras de directivos · todas las guías
Lo que hay detrás de estas operaciones
Los conceptos de esta página, explicados desde cero en la Academia. Gratis y sin cuenta.
- Qué dice y qué NO dice la hipótesis de eficienciaSi la compra de un directivo es pública y cualquiera puede leerla, ¿queda información dentro? Es la pregunta exacta que trae a esta página.
- Quién mueve realmente el mercado: los tipos de inversoresQuién hay al otro lado de cada orden, y qué sitio ocupan entre ellos los directivos de la propia empresa.
- Oferta, demanda y el precio: por qué sube y baja constantementeCómo acaba una noticia metida en el precio, y por qué la reacción a una venta declarada rara vez es la que uno esperaría.
Fuente: SEC EDGAR Formulario 4. Esto es una lista de hechos públicos, no asesoramiento financiero ni una recomendación de compra o venta.